The current stock price for Madrigal Pharmaceuticals Inc (MDGL) is $313.4. The stock experienced a significant increase during the last trading session, reaching $541.0 after opening at $313.4. It dipped to a low of $248.0 before ultimately closing at $330.94.
Madrigal Pharmaceuticals Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $377.46 on 02/26/25, and the lowest price during the same period was recorded at $200.63 on 10/23/24.
52-week price history of MDGL Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Madrigal Pharmaceuticals Inc’s current trading price is -16.97% away from its 52-week high, while its distance from the 52-week low is 56.21%. The stock’s price range during this period has fluctuated between $200.63 and $377.46. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 0.58 million for the day, which was evidently higher than the average daily volume of 0.33 million over the last three months.
Financial Performance and Market Capitalization
Madrigal Pharmaceuticals Inc (MDGL) has experienced a quarterly rise of 6.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 6.96B and boasts a workforce of 528 employees.
Analysts’ Ratings For Madrigal Pharmaceuticals Inc
As of right now, 11 analysts are rating Madrigal Pharmaceuticals Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 308.91, with a change in price of -42.48. Similarly, Madrigal Pharmaceuticals Inc recorded 348,030 in trading volume during the last 100 days, posting a change of -11.94%.
MDGL Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MDGL stands at 0.17. Similarly, the long-term debt-to-equity ratio is also 0.17.
MDGL Stock Stochastic Average
Madrigal Pharmaceuticals Inc’s raw stochastic average for the past 50 days is currently at 52.09%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 44.55%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 60.69% and 72.51%, respectively.
MDGL Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant gain of 12.28% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 6.73%. Over the past 30 days, the price of MDGL has fallen by 9.68%. And in the last five days, it has surged by 0.73%.
